Skip to main navigation Skip to search Skip to main content

Population pharmacokinetic modeling of sertraline treatment in patients with alzheimer disease: The DIADS-2 study

  • Claire H. Li
  • , Bruce G. Pollock
  • , Constantine G. Lyketsos
  • , Vijay Vaidya
  • , Lea T. Drye
  • , Margaret Kirshner
  • , Denise Sorisio
  • , Robert R. Bies
  • Indiana University-Purdue University Indianapolis
  • Indiana Clinical and Translational Sciences Institute (CTSI)
  • University of Toronto
  • Johns Hopkins University
  • University of Pittsburgh

Research output: Contribution to journalArticlepeer-review

14 Scopus citations
Original languageEnglish
Pages (from-to)234-239
Number of pages6
JournalJournal of Clinical Pharmacology
Volume53
Issue number2
DOIs
StatePublished - Feb 2013

Keywords

  • Alzheimer disease
  • Population pharmacokinetics
  • Sertraline

Fingerprint

Dive into the research topics of 'Population pharmacokinetic modeling of sertraline treatment in patients with alzheimer disease: The DIADS-2 study'. Together they form a unique fingerprint.

Cite this